MICHAEL WILLIAMS-HEALY: Open Payments
NPI 1003311127 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 18 payments from 11 companies in 2025. Trend: 2023 $111 · 2024 $357 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Cleerly, Inc. | 1 | $17 |
Products named: MOUNJARO, Rybelsus, VOQUEZNA, The Cologuard Plus Collection Kit, Kerendia, Auvelity, Wegovy, PAXLOVID.
Industry payments across NJ — which companies pay providers there.
